510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K143750Substantially Equivalent

MEG-2B Blood Glucose Monitoring System, MEG-2B Pro Blood Glucose Monitoring System

Apex Biotechnology Corp., Hsinchu, TW / Special, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K143750 is the FDA 510(k) clearance record for MEG-2B Blood Glucose Monitoring System, MEG-2B Pro Blood Glucose Monitoring System, a class II device, cleared for Apex BioTechnology Corp. on under FDA product code CGA (Glucose Oxidase, Glucose). FDA records list 35 510(k) clearances for Apex BioTechnology Corp., from to . As of , FDA records show no recalls naming K143750.

Clearance record

Decision date
Received
(127 days to decision)
Product code
CGA Glucose Oxidase, Glucose
Regulation
21 CFR 862.1345
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Apex BioTechnology Corp. #7, Li-Hsin Rd. V, Hsinchu Science Park, Hsinchu, TW
510(k) summary
Summary PDF
Third party review
No

Clearances, product code CGA

Trailing 12 months
1 clearance under product code CGA in the twelve months to October 2026, May 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code CGA, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20261
June 20260
July 20260
August 20260
September 20260
October 20260